Development and external validation of a model to predict recurrence in patients with non-muscle invasive bladder cancer.

ABSTRACT:

Background

Most patients initially diagnosed with non-muscle invasive bladder cancer (NMIBC) still have frequent recurrence after urethral bladder tumor electrodesiccation supplemented with intravesical instillation therapy, and their risk of recurrence is difficult to predict. Risk prediction models used to predict postoperative recurrence in patients with NMIBC have limitations, such as a limited number of included cases and a lack of validation. Therefore, there is an urgent need to develop new models to compensate for the shortcomings and potentially provide evidence for predicting postoperative recurrence in NMIBC patients.

Methods

Clinicopathologic characteristics and follow-up data were retrospectively collected from 556 patients with NMIBC who underwent transurethral

SUBMITTER: Tang J 

PROVIDER: S-EPMC11757240 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature